November 6, Wisconsin Health News
A new Medicaid benefit for residential substance use disorder treatment could go into effect Feb. 1, pending approval of a final plan submitted to the Joint Finance Committee.
The Centers for Medicare and Medicaid Services signed off on the plan last month. The committee will take a passive review process to the plan, meaning it'll go into effect unless members decide to meet.
DHS has begun pre-implementation outreach and communication activities about the program.
The benefit would cover short-term residential services in facilities that have been excluded from federal reimbursement because they're institutions for mental disease.
